BCRX - BioCryst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCRX is currently covered by 11 analysts with an average price target of $13.54. This is a potential upside of $6.19 (84.22%) from yesterday's end of day stock price of $7.35.

BioCryst Pharmaceuticals's activity chart (see below) currently has 128 price targets and 115 ratings on display. The stock rating distribution of BCRX is 89.29% BUY and 10.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.05% with an average time for these price targets to be met of 358.86 days.

Highest price target for BCRX is $30, Lowest price target is $7, average price target is $13.54.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 06-Aug-2024. First documented stock forecast 18-Feb-2014.

Currently out of the existing stock ratings of BCRX, 25 are a BUY (89.29%), 3 are a HOLD (10.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$-1.43 (-16.96%)

$6

2 months 30 days ago
(06-Aug-2024)

6/10 (60%)

$-0.87 (-11.05%)

42

Buy

$10

$1.57 (18.62%)

$10

2 months 30 days ago
(06-Aug-2024)

16/21 (76.19%)

$2.13 (27.06%)

510

Buy

$16

$7.57 (89.80%)

$15

2 months 30 days ago
(06-Aug-2024)

4/11 (36.36%)

$8.13 (103.30%)

149

Buy

$30

$21.57 (255.87%)

$30

2 months 30 days ago
(06-Aug-2024)

2/7 (28.57%)

$22.13 (281.19%)

245

Buy

$12

$3.57 (42.35%)

$12

5 months 29 days ago
(07-May-2024)

3/9 (33.33%)

$6.74 (128.14%)

348

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?

On average it took 358.86 days on average for the stock forecasts to be realized with a an average price target met ratio 55.05

Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 21 price targets and 14 ratings on BCRX

Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein with highest potential upside - $21.57

Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?

Gena Wang with lowest potential downside - -$1.43

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?